LUPIN - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 4.2

Here’s a detailed breakdown of the swing trade potential for LUPIN

📊 Technical & Momentum Indicators

Current Price: ₹1,985 is slightly above the 50 DMA (₹1,960) and nearly equal to the 200 DMA (₹1,981) — suggesting consolidation and potential for breakout.

RSI (58.2): Neutral-to-bullish zone. Not overbought, indicating room for upward movement.

MACD (-1.15): Slightly bearish crossover, but not strongly negative — could reverse with volume support.

Volume Surge: Current volume (9.16L) is significantly higher than 1-week average (6.97L), hinting at accumulation.

📈 Fundamental Strength

Market Cap: ₹90,648 Cr — large-cap stability.

ROCE (21.3%) & ROE (20.6%): Strong profitability metrics.

PEG Ratio (0.47): Undervalued relative to growth — attractive for swing traders.

Debt-to-Equity (0.32): Low leverage, financially sound.

EPS (₹71.9) vs Stock P/E (27.9): Reasonable valuation compared to Industry P/E (34.0).

Qtr Profit Var (115%): Strong earnings momentum.

📉 Concerns

MACD negative and FII holding slightly down (-0.21%) — mild caution.

Dividend Yield (0.60%): Low, but not a major factor for swing trades.

PAT Decline: ₹855 Cr to ₹773 Cr — slight dip, but not alarming given overall growth.

✅ Swing Trade Strategy

Optimal Entry Price: ₹1,960–₹1,975 range (near 50 DMA support). Wait for MACD to flatten or turn positive.

Target Exit Price: ₹2,300–₹2,350 (near resistance zone, just below 52-week high).

Stop Loss: ₹1,910 (below recent support and 50 DMA).

🧭 If You Already Hold the Stock

Hold until price approaches ₹2,300–₹2,350.

Exit if price breaks below ₹1,910 with volume confirmation.

Would you like a chart-based visual strategy or a comparison with another pharma stock for context?

Edit in a page